Skip to main content

Table 1 Baseline characteristics of patients with and without HSV reactivations

From: HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients

  

All patients (n = 153)

Without HSV reactivation (n = 113)

HSV reactivation (n = 40)

p-value

Female

Number (%)

38 (24.8)

28 (24.8)

10 (25)

1.000

Age

Median (IQR)

60.8 [50.2; 69.5]

60.8 [50.1; 68.8]

61.9 [50.9; 70.8]

0.546

BMI

Median (IQR)

28.8 [25.3; 33]

29 [25.4; 33]

27.7 [24.4; 33.2]

0.629

Diabetes

Number (%)

48 (31.4)

40 (35.4)

8 (20)

0.078

Other chronic diseases*

Number (%)

73 (47.7)

55 (48.7)

18 (45)

0.716

SOFA score

Median (IQR)

5 [3; 7]

5 [3; 7]

5 [4; 7]

0.468

Maximal body temperature (°C)

Median (IQR)

38.2 [37.5; 39.1]

38 [37.5; 39]

38.9 [37.8; 39.3]

0.029

Mechanical ventilation

    

0.009

None

Number (%)

16 (10.5)

14 (12.4)

2 (5)

 

CPAP/HFNO

Number (%)

85 (55.6)

69 (61.1)

16 (40)

 

IMV/PEEP < 10 mmHg

Number (%)

0

0

0

 

IMV/PEEP > 10 mmHg

Number (%)

40 (26.1)

22 (19.5)

18 (45)

 

ECMO

Number (%)

12 (7.8)

8 (7.1)

4 (10)

 

Lymphocytes count (/mm3)

Median (IQR)

885 [595; 1220]

890 [610; 1230]

880 [570; 1210]

0.784

Initial use of corticosteroid

Number (%)

108 (70.6)

86 (76.1)

22 (55)

0.016

Tocilizumab/anakinra

Number (%)

31 (20.3)

25 (22.1)

6 (15)

0.492

CRP (mg/L)

Median (IQR)

138.5 [77.5; 204.5]

125 [64.5; 183.5]

180.5 [115.5; 252.5]

0.001

D-Dimers (mg/mL)

Median (IQR)

962 [588; 2043]

952 [564; 1768]

1056.5 [682; 4376]

0.195

Ferritin (ng/mL)

Median (IQR)

1159 [592; 1979]

1060 [526; 1915]

1348 [832; 2370]

0.110

LDH (UI/L)

Median (IQR)

438.5 [337; 606.9]

417 [331; 538]

504.9 [388; 695]

0.019

  1. HSV-positive and -negative patients were compared with Chi-square, Fisher and Wilcoxon tests IQR Inter Quartile Range. These data were collected on ICU admission (day one or two)
  2. HSV Herpes simplex virus; BMI Body Mass Index; SOFA Sequential Organ Failure Assessment; CPAP Continuous Positive Airway Pressure; HFNO High-Flow Nasal Oxygenotherapy; IMV Invasive Mechanical Ventilation; PEEP Positive End Expiratory Pressure; ECMO Extra-Corporeal Membrane Oxygenation; CRP C Reactive Protein; LDH Lactate Dehydrogenase
  3. *Other chronic diseases were hepatic, heart, respiratory, renal or hematologic diseases, according to the Knaus definitions
  4. HSV-positive and -negative patients were compared with Chi-square, Fisher and Wilcoxon tests IQR Inter Quartile Range. These data were collected on ICU admission (day one or two)
  5. HSV Herpes simplex virus; BMI Body Mass Index; SOFA Sequential Organ Failure Assessment; CPAP Continuous Positive Airway Pressure; HFNO High-Flow Nasal Oxygenotherapy; IMV Invasive Mechanical Ventilation; PEEP Positive End Expiratory Pressure; ECMO Extra-Corporeal Membrane Oxygenation; CRP C Reactive Protein; LDH Lactate Dehydrogenase
  6. *Other chronic diseases were hepatic, heart, respiratory, renal or hematologic diseases, according to the Knaus definitions